Liquiritin Attenuates Lipopolysaccharides-Induced Cardiomyocyte Injury via an AMP-Activated Protein Kinase-Dependent Signaling Pathway

Background: Liquiritin (LIQ) is a traditional Chinese medicine that has been reported to regulate inflammation, oxidative stress and cell apoptosis. However, the beneficial effects of LIQ in lipopolysaccharides (LPS)-induced septic cardiomyopathy (SCM) has not been reported. The primary goal of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Mou, Shan-Qi, Zhou, Zi-Ying, Feng, Hong, Zhang, Nan, Lin, Zheng, Aiyasiding, Xiahenazi, Li, Wen-Jing, Ding, Wen, Liao, Hai-Han, Bian, Zhou-Yan, Tang, Qi-Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162655/
https://www.ncbi.nlm.nih.gov/pubmed/34054527
http://dx.doi.org/10.3389/fphar.2021.648688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162655/
https://www.ncbi.nlm.nih.gov/pubmed/34054527
http://dx.doi.org/10.3389/fphar.2021.648688

Ejemplares similares